Arena Pharma Shares Tick Higher As CEO Retires

By Wallace WitkowskiMarketWatch Pulse

Arena Pharmaceuticals Inc. shares rose in the extended session Monday following an announcement by the company its chief executive was retiring. Arena shares advanced 5.1% to $2.26. The drug developer said co-founder Jack Lief was retiring as president and CEO, and that Harry Hixson will serve as interim CEO. Arena said it will initiate a search for a new CEO immediately.

Copyright © 2015 MarketWatch, Inc.

Continue Reading Below